@article{TAU18069,
author = {Netty Kinsella and Jozien Helleman and Sophie Bruinsma and Sigrid Carlsson and Declan Cahill and Christian Brown and Mieke Van Hemelrijck},
title = {Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices},
journal = {Translational Andrology and Urology},
volume = {7},
number = {1},
year = {2018},
keywords = {},
abstract = {In the last decade, active surveillance (AS) has emerged as an acceptable choice for low-risk prostate cancer (PC), however there is discordance amongst large AS cohort studies with respect to entry and monitoring protocols. We systematically reviewed worldwide AS practices in studies reporting ≥5 years follow-up. We searched PubMed and Medline 2000-now and identified 13 AS cohorts. Three key areas were identified: (I) patient selection; (II) monitoring protocols; (III) triggers for intervention—(I) all studies defined clinically localised PC diagnosis as T2b disease or less and most agreed on prostate-specific antigen (PSA) threshold (},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/18069}
}